Activist 13D/13G Filings - Zyla Life Sciences (ZCOR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2021-01-29
08:51 am
Sale
13GZyla Life Sciences
ZCOR
Tekla Capital Management LLC0
0.000%
-656,921decrease
(Position Closed)
View
2020-05-22
4:07 pm
Sale
13DZyla Life Sciences
ZCOR
CR Group L.P.0
0.000%
-7,023,333decrease
(Position Closed)
View
2020-03-26
4:26 pm
Purchase
13DZyla Life Sciences
ZCOR
Assertio Therapeutics Inc
ASRT
4,854,863
51.000%
4,854,863increase
(New Position)
View
2020-03-25
8:53 pm
Unchanged
13DZyla Life Sciences
ZCOR
CR Group L.P.7,023,333
58.700%
0
(Unchanged)
View
2020-02-13
5:28 pm
Unchanged
13GZyla Life Sciences
ZCOR
Broadfin Capital LLC0
0.000%
0
(Unchanged)
View
2020-02-13
5:25 pm
Purchase
13GZyla Life Sciences
ZCOR
CI INVESTMENTS INC.935,161
9.990%
935,161increase
(New Position)
View
2020-02-13
4:23 pm
Purchase
13GZyla Life Sciences
ZCOR
HIGHBRIDGE CAPITAL MANAGEMENT LLC2,260,624
9.990%
2,260,624increase
(New Position)
View
2020-02-12
5:15 pm
Sale
13GZyla Life Sciences
ZCOR
Riva Ridge Capital Management LP938,661
10.000%
-300,000decrease
(-24.22%)
View
2020-01-24
08:03 am
Purchase
13GZyla Life Sciences
ZCOR
Tekla Capital Management LLC656,921
7.000%
656,921increase
(New Position)
View